Lisa is a biological scientist by training and completed her PhD at the University of Birmingham in 2015. She has since undertaken research placements at Queen’s University Belfast (UK), University California Irvine (USA) and the University of Melbourne (Australia). She is now conducting pioneering research in the fields of extracellular matrix biology, ocular disease and therapeutics. Over the last decade, she has focussed on understanding how inflammation and dysfunctions in extracellular matrix can lead to blinding diseases including glaucoma, age-related macular degeneration and uveitis. This has led to her identifying and developing new immuno- and anti-scarring therapies to treat blinding diseases and she has developed and patented technologies used for delivering drugs into the eye.
Lisa teaches on Biomedical Science, Clinical Medicine and Pharmacy undergraduate degrees and hosts multiple post-graduate research projects with PhD students based at Birmingham and Melbourne. She is also the Access to Birmingham Lead Tutor for Biomedical Science as part of the widening participation programmes. Dr Hill is leading PhD projects within the ‘LifETIME (Engineered Tissues for Discovery, Industry and Medicine) CDT partnership between the University of Glasgow, the University of Birmingham, Aston University and CÚRAM (Science Foundation Ireland). She is also an elected member of the Royal Society of Biology and is the Institute’s Cross-cutting Research Theme Lead for Discovery and Translational Science.